| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.032 | 0.5 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |